Back to search results

Dexcom Continuous Glucose Monitoring System Use in a Real-World Setting

This study is looking at how the Dexcom Continuous Glucose Monitoring (CGM) System (G6, G6 Pro, or G7) works for people with diabetes in their daily lives. The goal is to understand how using this device impacts people. Researchers will collect information from 5,000 participants. You may be able to join if you have diabetes, are at least 2 years old, and use a Dexcom CGM System according to its instructions. You also need to have had an HbA1C (a blood test that shows your average blood sugar over 2-3 months) measurement within three months before starting to use the Dexcom CGM. The study will measure how people report their experiences (Patient Reported Outcomes) over 4 years. The current recruitment status is unclear.

Study design
This is an observational study, meaning researchers will collect data without giving specific treatments. It is an open-label study, so you and your doctors will know you are using the Dexcom CGM System. About 5,000 people are expected to join.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Your experiences and outcomes will be followed for 4 years.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06483945

Dexcom Continuous Glucose Monitoring System Use in aReal-World, Global Registry (Dexcom Global Registry)

Active, Not Recruiting
Not specifiedAges 2+Observational
DexCom, Inc.
~5,000 participants
Updated 2026-09-02 on ClinicalTrials.gov
What's tested:Dexcom CGM G6/G6 Pro/G7

At a glance

Recruiting sites
0 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Patient Reported Outcomes (PROs)
Measured over 4 years

Conditions

Diabetes

Explore related trials

Diabetes Mellitus

Where it's being run

2 sites across 2 states
Georgia1
Nevada1

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Meets Dexcom CGM System Indications for Use (IFU) per approved commercial labeling
Has at least one HbA1C (Hemoglobin a1c) measurement within three (3) months prior to the Dexcom CGM System use start date that is at least three (3) months after any prior CGM use
Subject is willing and able to use Dexcom CGM System according to approved product labeling
Subject is willing and able to complete applicable patient reported outcome assessments/ surveys
Subject is willing and able to comply with the protocol
Subject is willing and able to comply with provider requirements for at least two provider encounters per year according to applicable clinical practice guidelines
Subject or the subject's legally authorized representative must provide written informed consent prior to any study-related data collection or be enrolled under an IRB/EC approved waiver of consent

Exclusion

Is contraindicated for a Dexcom CGM System per approved commercial labeling
In the Investigator's opinion, the subject is not considered to be a suitable candidate

What this trial measures

  • Patient Reported Outcomes (PROs)4 years

    Patients will be asked to complete multiple questionnaires over a period of 4 years for data to be analyzed and reported.